References
- Kosoković F., Večerina S. Contribution to therapy of dysphonia plica ventricularis. Laryngoscope 1977; 87: 408–14
- Taffet S. M., Eurell T. E., Russell S. W. Regulation of macrophage mediated tumor cell killing by prostaglandins: a comparison of the effect of PGE2 and PGI2. BR J Cancer 1980; 41: 204–8
- Droller J. J., Schneider M. V., Permann P. A possible role of prostaglandins in the inhibition of natural and antibody dependent cell-mediated cytotoxicity against tumor cells. Cell Immunol 1978; 39: 165–77
- O'Flaherty J. T. Biology of disease: lipid mediators of inflammation and allergy. Lab Invest 1982; 47: 314–29
- Bennet A., Carter R. L., Stamford I. F. Prostaglandin-like material extracted from squamous carcinomas of the head and neck. Br J Cancer 1980; 41: 204–8
- Panje W. R. Regression of head and neck carcinoma with a prostaglandin synthesis inhibitor. Arch Otolaryngol 1981; 107: 658–63
- Klapan I., Katie V., čulo F., Ćuk V. Prognostic significance of plasma prostglandin E concentration in patients with head and neck cancer. J Cancer Res Clin Oncol 1992; 118: 308–13
- Jung T. TK., Juhn S. K., Hwang D., Stewart R. Prostglandins, leukotriens and other arachidonic acid metabolites in nasal polyps and nasal mucosa. Laryngoscope 1987; 97: 184–9
- Včerina Volić S., Klapan I., Katić V. Biochemical analysis of vocal fold polyps. Acta Otolaryngol (Stockh) 1992; 112: 358–61